Emerging Trends and Future Prospects of GLP-1 Receptor Agonists: Focus on Ozempic and Semaglutide in 2025
Glucagon-like peptide-1 (GLP-1) receptor agonists have revolutionized the management of type 2 diabetes adn obesity over the past decade. As we approach 2025, ongoing research and clinical developments suggest promising…
Read More »